The freezing process may damage the peptide structure, potentially resulting in diminished blood sugar control or weight loss effectsnot toxic byproducts
While our bodies are designed to create it, factors like environmental stressors, age, and a busy lifestyle can impact our natural levels
Current GLP-1 drugs work on one or two pathways, but retatrutide adds a third by targeting the glucagon receptor
At the same time, we are facing an exciting multifaceted future, with several novel developments on the horizon with the potential to change the clinic setting, including the development of oral GLP-1 receptor agonists and the emerging formulations of GIP receptor agonists and dual and triple receptor agonists, which have shown clear therapeutic potential
iek Kaya et al
However, the risk increases when combined with insulin or sulfonylureas